Pneumococcal Vaccine Market Share

On the basis of regional analysis, the pneumococcal vaccine market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. North America industry is set to hold largest revenue share by 2037, backed by growing demand for efficient disease prevention vaccine across the region. Additionally, advanced research and development in healthcare sector in Asia Pacific that leads to manufacture of advanced and cost-effective vaccine is anticipated to drive the market growth in the region during the forecast period. The adoption of advanced and high end vaccine in developing regions such as China, India and Japan is increasing and in order to gain a competitive edge, the medical equipment manufacturers in this region are coming up with newer vaccine to prevent pneumococcal disorders.